These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 8585897)

  • 1. Plasma concentration of endothelin and arterial pressure in patients with ADPKD.
    Giusti R; Neri M; Angelini D; Carlini A; Fiorini I; Bigongiari P; Antonelli A
    Contrib Nephrol; 1995; 115():118-21. PubMed ID: 8585897
    [No Abstract]   [Full Text] [Related]  

  • 2. Sympathetic activity and blood pressure pattern in autosomal dominant polycystic kidney disease hypertensives.
    Cerasola G; Vecchi M; Mulè G; Cottone S; Mangano MT; Andronico G; Contorno A; Parrino I; Renda F; Pavone G
    Am J Nephrol; 1998; 18(5):391-8. PubMed ID: 9730562
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of renin-angiotensin-aldosterone system and of sympathetic activity in arterial hypertension associated with autosomal dominant polycystic kidney disease.
    Cerasola G; Li Vecchi M; Mulé G; Cottone S; Mangano MT; Andronico G; Contomo A; Parrino IA; Renda F; Pavone G; Scialabba A
    Contrib Nephrol; 1997; 122():22-7. PubMed ID: 9399032
    [No Abstract]   [Full Text] [Related]  

  • 4. Borderline hypertensive autosomal dominant polycystic kidney disease patients have enhanced production of renal dopamine. Normalization of renal haemodynamics by DOPA infusion.
    Barendregt JN; Florijn KW; Muizert Y; Chang PC
    Nephrol Dial Transplant; 1995; 10(8):1332-41. PubMed ID: 8538923
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Least square regression analysis of arterial pressure estimators contributing to early renal failure in ADPKD.
    Gonzalo A; Gallego A; Rivera M; Orte L; Ortuño J
    Contrib Nephrol; 1995; 115():171-6. PubMed ID: 8585910
    [No Abstract]   [Full Text] [Related]  

  • 6. Renal vascular resistance and renin-angiotensin system in the pathogenesis of early hypertension in autosomal dominant polycystic kidney disease.
    Ramunni A; Saracino A; Esposito T; Saliani MT; Coratelli P
    Hypertens Res; 2004 Apr; 27(4):221-5. PubMed ID: 15127878
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hypertension in polycystic kidney disease type 1 and 2 and its effect on the age of onset of end-stage renal disease.
    Torra R; Badenas C; Pérez L; Estivill X; Darnell A
    Contrib Nephrol; 1997; 122():28-30. PubMed ID: 9399033
    [No Abstract]   [Full Text] [Related]  

  • 8. Progress in blood pressure control in autosomal dominant polycystic kidney disease.
    Ecder T; Edelstein CL; Fick-Brosnahan GM; Johnson AM; Duley IT; Gabow PA; Schrier RW
    Am J Kidney Dis; 2000 Aug; 36(2):266-71. PubMed ID: 10922304
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Blood pressure, functional and morphological study of kidneys in children with autosomal dominant polycystic kidney disease].
    Seeman T; Vondrichová H; Strízová J; Sikut M; Janda J; Schärer K
    Cas Lek Cesk; 1999 Mar; 138(6):178-84. PubMed ID: 10510532
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Relationship between renal size and blood pressure profile in patients with autosomal dominant polycystic kidney disease without renal failure].
    Sans Atxer L; Roca-Cusachs A; Torra R; Calero F; Arias P; Ballarin J; Fernández-Llama P
    Nefrologia; 2010; 30(5):567-72. PubMed ID: 20882096
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Contribution of renal innervation to hypertension in rat autosomal dominant polycystic kidney disease.
    Gattone VH; Siqueira TM; Powell CR; Trambaugh CM; Lingeman JE; Shalhav AL
    Exp Biol Med (Maywood); 2008 Aug; 233(8):952-7. PubMed ID: 18480417
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genesis and significance of hypertension in autosomal dominant polycystic kidney disease.
    Zeier M; Ritz E; Geberth S; Gonzalo A
    Nephron; 1994; 68(2):155-8. PubMed ID: 7830851
    [No Abstract]   [Full Text] [Related]  

  • 13. Hypertension in autosomal dominant polycystic kidney disease: a meta-analysis.
    Marlais M; Cuthell O; Langan D; Dudley J; Sinha MD; Winyard PJ
    Arch Dis Child; 2016 Dec; 101(12):1142-1147. PubMed ID: 27288429
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Renal concentrating capacity is linked to blood pressure in children with autosomal dominant polycystic kidney disease.
    Seeman T; Dusek J; Vondrák K; Bláhová K; Simková E; Kreisinger J; Dvorák P; Kyncl M; Hríbal Z; Janda J
    Physiol Res; 2004; 53(6):629-34. PubMed ID: 15588131
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sodium-lithium countertransport in autosomal polycystic kidney disease.
    Li Vecchi M; Andronico G; Ferrara L; Renda F; Parrino IA; Pavone G; Mulé G; Ferrantelli A; Di Natale E; Cerasola G
    Contrib Nephrol; 1997; 122():31-4. PubMed ID: 9399034
    [No Abstract]   [Full Text] [Related]  

  • 16. Autosomal dominant polycystic kidney disease: role of the renin-angiotensin system in raised blood pressure in progression of renal and cardiovascular disease.
    Lawson CR; Doulton TW; MacGregor GA
    J Renin Angiotensin Aldosterone Syst; 2006 Sep; 7(3):139-45. PubMed ID: 17094050
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Renal volume, renin-angiotensin-aldosterone system, hypertension, and left ventricular hypertrophy in patients with autosomal dominant polycystic kidney disease.
    Schrier RW
    J Am Soc Nephrol; 2009 Sep; 20(9):1888-93. PubMed ID: 19696226
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of endothelin and nitric oxide in the pathogenesis of arterial hypertension in autosomal dominant polycystic kidney disease.
    Merta M; Reiterová J; Rysavá R; Tesar V; Závada J; Jáchymová M; Zima T
    Physiol Res; 2003; 52(4):433-7. PubMed ID: 12899655
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Elevated blood pressure profile and left ventricular mass in children and young adults with autosomal dominant polycystic kidney disease.
    Zeier M; Geberth S; Schmidt KG; Mandelbaum A; Ritz E
    J Am Soc Nephrol; 1993 Feb; 3(8):1451-7. PubMed ID: 8490116
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vasopressin, copeptin, and renal concentrating capacity in patients with autosomal dominant polycystic kidney disease without renal impairment.
    Zittema D; Boertien WE; van Beek AP; Dullaart RP; Franssen CF; de Jong PE; Meijer E; Gansevoort RT
    Clin J Am Soc Nephrol; 2012 Jun; 7(6):906-13. PubMed ID: 22516290
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.